These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 16354825

  • 1. Molecular surveillance of mutations in dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum in Ethiopia.
    Gebru-Woldearegai T, Hailu A, Grobusch MP, Kun JF.
    Am J Trop Med Hyg; 2005 Dec; 73(6):1131-4. PubMed ID: 16354825
    [Abstract] [Full Text] [Related]

  • 2. Point mutations in the dihydrofolate reductase and dihydropteroate synthase genes of Plasmodium falciparum and resistance to sulfadoxine-pyrimethamine in Sri Lanka.
    Hapuarachchi HC, Dayanath MY, Bandara KB, Abeysundara S, Abeyewickreme W, de Silva NR, Hunt SY, Sibley CH.
    Am J Trop Med Hyg; 2006 Feb; 74(2):198-204. PubMed ID: 16474070
    [Abstract] [Full Text] [Related]

  • 3. Prediction of Plasmodium falciparum resistance to sulfadoxine/pyrimethamine in vivo by mutations in the dihydrofolate reductase and dihydropteroate synthetase genes: a comparative study between sites of differing endemicity.
    Alifrangis M, Enosse S, Khalil IF, Tarimo DS, Lemnge MM, Thompson R, Bygbjerg IC, Rønn AM.
    Am J Trop Med Hyg; 2003 Dec; 69(6):601-6. PubMed ID: 14740875
    [Abstract] [Full Text] [Related]

  • 4. Distinct haplotypes of dhfr and dhps among Plasmodium falciparum isolates in an area of high level of sulfadoxine-pyrimethamine (SP) resistance in eastern Sudan.
    Al-Saai S, Kheir A, Abdel-Muhsin AM, Al-Ghazali A, Nwakanma D, Swedberg G, Babiker HA.
    Infect Genet Evol; 2009 Sep; 9(5):778-83. PubMed ID: 19379843
    [Abstract] [Full Text] [Related]

  • 5. Validation of a simplified method for using molecular markers to predict sulfadoxine-pyrimethamine treatment failure in African children with falciparum malaria.
    Kyabayinze D, Cattamanchi A, Kamya MR, Rosenthal PJ, Dorsey G.
    Am J Trop Med Hyg; 2003 Sep; 69(3):247-52. PubMed ID: 14628939
    [Abstract] [Full Text] [Related]

  • 6. A molecular epidemiologic study of point mutations for pyrimethamine-sulfadoxine resistance of Plasmodium falciparum isolates from Lao PDR.
    Toma H, Imada Y, Vannachone B, Miyagi M, Kobayashi J, Uechi G, Pethuvang R, Manivong K, Phompida S, Sato Y.
    Southeast Asian J Trop Med Public Health; 2005 May; 36(3):602-4. PubMed ID: 16124424
    [Abstract] [Full Text] [Related]

  • 7. Associations of antifolate resistance in vitro and point mutations in dihydrofolate reductase and dihydropteroate synthetase genes of Plasmodium falciparum.
    Biswas S.
    J Postgrad Med; 2004 May; 50(1):17-20. PubMed ID: 15047993
    [Abstract] [Full Text] [Related]

  • 8. Therapeutic efficacy of sulfadoxine-pyrimethamine and prevalence of resistance markers in Tanzania prior to revision of malaria treatment policy: Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase mutations in monitoring in vivo resistance.
    Mugittu K, Ndejembi M, Malisa A, Lemnge M, Premji Z, Mwita A, Nkya W, Kataraihya J, Abdulla S, Beck HP, Mshinda H.
    Am J Trop Med Hyg; 2004 Dec; 71(6):696-702. PubMed ID: 15642957
    [Abstract] [Full Text] [Related]

  • 9. Polymorphisms in Plasmodium falciparum dhfr and dhps genes and age related in vivo sulfadoxine-pyrimethamine resistance in malaria-infected patients from Nigeria.
    Happi CT, Gbotosho GO, Folarin OA, Akinboye DO, Yusuf BO, Ebong OO, Sowunmi A, Kyle DE, Milhous W, Wirth DF, Oduola AM.
    Acta Trop; 2005 Sep; 95(3):183-93. PubMed ID: 16023986
    [Abstract] [Full Text] [Related]

  • 10. The implication of dihydrofolate reductase and dihydropteroate synthetase gene mutations in modification of Plasmodium falciparum characteristics.
    A-Elbasit IE, Alifrangis M, Khalil IF, Bygbjerg IC, Masuadi EM, Elbashir MI, Giha HA.
    Malar J; 2007 Aug 08; 6():108. PubMed ID: 17686173
    [Abstract] [Full Text] [Related]

  • 11. Prevalence of sulfadoxine-pyrimethamine resistance-associated mutations in dhfr and dhps genes of Plasmodium falciparum three years after SP withdrawal in Bahir Dar, Northwest Ethiopia.
    Hailemeskel E, Kassa M, Taddesse G, Mohammed H, Woyessa A, Tasew G, Sleshi M, Kebede A, Petros B.
    Acta Trop; 2013 Dec 08; 128(3):636-41. PubMed ID: 24055717
    [Abstract] [Full Text] [Related]

  • 12. Increasing prevalence of wildtypes in the dihydrofolate reductase gene of Plasmodium falciparum in an area with high levels of sulfadoxine/pyrimethamine resistance after introduction of treated bed nets.
    Alifrangis M, Lemnge MM, Rønn AM, Segeja MD, Magesa SM, Khalil IF, Bygbjerg IC.
    Am J Trop Med Hyg; 2003 Sep 08; 69(3):238-43. PubMed ID: 14628937
    [Abstract] [Full Text] [Related]

  • 13. Two mutations in dihydrofolate reductase combined with one in the dihydropteroate synthase gene predict sulphadoxine-pyrimethamine parasitological failure in Ugandan children with uncomplicated falciparum malaria.
    Talisuna AO, Nalunkuma-Kazibwe A, Langi P, Mutabingwa TK, Watkins WW, Van Marck E, Egwang TG, D'Alessandro U.
    Infect Genet Evol; 2004 Dec 08; 4(4):321-7. PubMed ID: 15374529
    [Abstract] [Full Text] [Related]

  • 14. [Monitoring the chemoresistance of Plasmodium falciparum malaria in Yopougon (Abidjan): in vivo study of chloroquine sensitivity and evaluation of pyrimethamine resistance following the analysis of point mutation in the dihydrofolate reductase gene].
    Djaman AJ, Basco LK, Mazabraud A.
    Sante; 2002 Dec 08; 12(4):363-7. PubMed ID: 12626289
    [Abstract] [Full Text] [Related]

  • 15. Principal role of dihydropteroate synthase mutations in mediating resistance to sulfadoxine-pyrimethamine in single-drug and combination therapy of uncomplicated malaria in Uganda.
    Dorsey G, Dokomajilar C, Kiggundu M, Staedke SG, Kamya MR, Rosenthal PJ.
    Am J Trop Med Hyg; 2004 Dec 08; 71(6):758-63. PubMed ID: 15642967
    [Abstract] [Full Text] [Related]

  • 16. Plasmodium falciparum dhfr but not dhps mutations associated with sulphadoxine-pyrimethamine treatment failure and gametocyte carriage in northern Ghana.
    Mockenhaupt FP, Teun Bousema J, Eggelte TA, Schreiber J, Ehrhardt S, Wassilew N, Otchwemah RN, Sauerwein RW, Bienzle U.
    Trop Med Int Health; 2005 Sep 08; 10(9):901-8. PubMed ID: 16135198
    [Abstract] [Full Text] [Related]

  • 17. Molecular epidemiology of malaria in Cameroon. XXVII. Clinical and parasitological response to sulfadoxine-pyrimethamine treatment and Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase alleles in Cameroonian children.
    Tahar R, Basco LK.
    Acta Trop; 2007 Aug 08; 103(2):81-9. PubMed ID: 17640607
    [Abstract] [Full Text] [Related]

  • 18. Mutations in Plasmodium falciparum dihydrofolate reductase and dihydropteroate synthase and epidemiologic patterns of pyrimethamine-sulfadoxine use and resistance.
    Plowe CV, Cortese JF, Djimde A, Nwanyanwu OC, Watkins WM, Winstanley PA, Estrada-Franco JG, Mollinedo RE, Avila JC, Cespedes JL, Carter D, Doumbo OK.
    J Infect Dis; 1997 Dec 08; 176(6):1590-6. PubMed ID: 9395372
    [Abstract] [Full Text] [Related]

  • 19. Therapeutic efficacy of sulfadoxine-pyrimethamine and the prevalence of molecular markers of resistance in under 5-year olds in Brazzaville, Congo.
    Ndounga M, Tahar R, Basco LK, Casimiro PN, Malonga DA, Ntoumi F.
    Trop Med Int Health; 2007 Oct 08; 12(10):1164-71. PubMed ID: 17956498
    [Abstract] [Full Text] [Related]

  • 20. Short report: molecular markers associated with Plasmodium falciparum resistance to sulfadoxine-pyrimethamine in the Democratic Republic of Congo.
    Cohuet S, Bonnet M, Van Herp M, Van Overmeir C, D'Alessandro U, Guthmann JP.
    Am J Trop Med Hyg; 2006 Jul 08; 75(1):152-4. PubMed ID: 16837723
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.